Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07398482 · ClinicalTrials.gov registry record · NA

PrEPwise Pilot Among Black Women in Eastern Virginia

A NA study, sponsored by Boston University.

Not yet
Registry status
NA
Development phase
108
Enrollment target

NCT07398482: Clinical Trial NA study, sponsored by Boston University.

NCT07398482 is a NA study that has not yet begun recruiting, run by Boston University. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07398482, a NA study, has not yet begun recruiting, sponsored by Boston University.

NOT YET RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

HIV is a virus that affects many people, but Black women in the U.S. are a population at a much higher risk of getting it compared to white women-about 18 times higher. Pre-exposure prophylaxis (PrEP), a medicine if taken as recommended by a clinician can prevent HIV almost completely (99% effective). The problem is that many Black women, especially those living in the Southern U.S., don't know about this medicine called PrEP or find it hard to access it. To address this, healthcare providers sometimes use "decision aids" which are tools, like brochures or videos, designed to help people understand their medical options and make informed choices based on what's important to them. While these tools have worked well for other health issues, they haven't been widely used for preventing HIV. The challenges are doctors do not have enough time to explain PrEP fully to patients during clinic visits and also some Black women do not trust the healthcare system because of a long history of unfair treatment toward Black communities. Community health workers (CHWs) are trained health workers from the same communities as their patients and can facilitate their ability to provide culturally appropriate health education and information consistent with patients' values and needs. Because of this, patients are often more comfortable talking to them. This project aims to test the acceptability and effectiveness of a decision tool to be integrated into HIV testing services to help Black women decide if PrEP is right for them. The investigators are calling this intervention PrEPwise. A tool originally designed for women dealing with opioid addiction will be adapted to fit the needs of Black women living in the South. The long-term goal of this project is to make it easier for Black women to learn about PrEP and decide whether to use it, ultimately helping lower the number of new HIV cases in Black women.

Primary Outcome

Acceptability will be assessed using the client satisfaction survey (CSQ-8), an 8-item instrument with 4 possible responses for each item (1-4). Total scores range from 8 to 32; higher scores indicating greater satisfaction.

Interventions

  • OTHER Usual care
  • BEHAVIORAL PrEPwise

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2027-04
Est. Completion 2028-07
Phase NA
Boston University

185 total trials

What is known before NCT07398482 opens enrollment

NCT07398482 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.

NCT07398482 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07398482 about?

NCT07398482 is a clinical study titled "PrEPwise Pilot Among Black Women in Eastern Virginia". HIV is a virus that affects many people, but Black women in the U.S. are a population at a much higher risk of getting it compared to white women-about 18 times higher. Pre-exposure prophylaxis (PrEP), a medicine if taken as recommended by a clinician can prevent HIV almost completely (99% effective...

What is the current status of trial NCT07398482?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2027-04. Estimated completion is 2028-07.

What interventions are being tested in trial NCT07398482?

The interventions under investigation include: Usual care (OTHER), PrEPwise (BEHAVIORAL).

Who is sponsoring clinical trial NCT07398482?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07398482's enrollment target sits among peer trials

108 825th of 2000 higher than 1,171 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07398482, the US trial registry maintained by the National Library of Medicine. NCT07398482 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.